Princeton Alpha Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Princeton Alpha Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-9,183	Closed	-$360K	–	451
2017 Q1	$360K	Buy	+9,183	New	+$292K	0.12%	296
2016 Q3	–	Sell	-13,247	Closed	-$313K	–	1016
2016 Q2	$313K	Buy	+13,247	New	+$327K	0.06%	510
2016 Q1	–	Sell	-7,871	Closed	-$405K	–	1009
2015 Q4	$405K	Buy	+7,871	New	+$382K	0.07%	403

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Princeton Alpha Management's PTLA Position: Q2 2017 in Review

Princeton Alpha Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2017, closing a stake of 9,183 shares — an estimated $360K sold.

Princeton Alpha Management first reported a position in PTLA in Q4 2015 and held it in 3 quarters. The position peaked at $405K in Q4 2015. 206 funds tracked by Wall St. Rank hold PTLA as of Q2 2017.

Princeton Alpha Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 9,183 Portola Pharmaceuticals, Inc. shares in Q2 2017, an estimated $360K.
Princeton Alpha Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 3 quarters.
Princeton Alpha Management's Portola Pharmaceuticals, Inc. position peaked at $405K in Q4 2015.
206 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.